ClinicalTrials.gg
Drug

Bintrafusp alfa clinical trials

Also written M7824 and MSB0011359C.

studies test it
46
open now
1
in phase 3
3
first study started
2015

How each study uses bintrafusp alfa is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the bintrafusp alfa studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Bintrafusp alfa
30
Anti-PDL1/TGFb Trap MSB0011359C
11

Development codes

M7824
38
MSB0011359C
17

Studies by the year they started

46 studies that test it; most in 2020 (16)

Studies that test bintrafusp alfa, by start year
YearStudies
20151
20161
20189
20194
202016
202113
20222

Who runs them

Industry 11 · Other 35

National Cancer Institute (NCI) (15) · M.D. Anderson Cancer Center (10) · EMD Serono Research & Development Institute, Inc. (9) · Institut Bergonié (1) · Fundación GECP (1) · Merck KGaA, Darmstadt, Germany (1) · The University of Hong Kong (1) · Yonsei University (1)

Often tested with

Tested in the same studies.

Immunocytokine NHS-IL12 (3) · Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101 (1) · CEA-MUC-1-TRICOM Vaccine CV301 (1) · Nogapendekin alfa inbakicept (1) · SX-682 (1) · Cisplatin (1) · Carboplatin (1) · Pimasertib (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3

Studies that test bintrafusp alfa.

Studies

Open first, then newest update. How each study uses bintrafusp alfa is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 46

See all 46 studies that test bintrafusp alfa →

Given beside what is tested · 10 — bintrafusp alfa is usual care or a partner of the new treatment

Codes

What other systems call bintrafusp alfa · ClinicalTrials.gg INT017419

  • UNII (FDA) NW9K8C1JN3BINTRAFUSP ALFAOne source FDA
  • NCI Thesaurus C124229Bintrafusp AlfaOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.